Mepolizumab Biosimilar – Anti-IL5 mAb – Research Grade

Reference:

General information on Anti-IL5(Homo sapiens) (Mepolizumab) Monoclonal Antibody

Mepolizumab is a fully humanized recombinant IgG1 kappa monoclonal antibody directed against IL-5 produced in Chinese hamster ovary cells. (EGPA) and eosinophilia syndrome (HES). The pathogenesis of eosinophils is complex, but IL-5 is considered a key eosinophilic factor, involved in the differentiation, recruitment, activation and prolonged survival of eosinophils in peripheral tissues. Activated eosinophils further stimulate the inflammatory response, and also induce tissue damage and promote fibrosis, all of which contribute to the multifactorial symptoms of eosinophilic disease. Mepolizumab is used to treat severe asthma and is sold under the trade name Nucala.

Product nameMepolizumab Biosimilar - Anti-IL5 mAb - Research Grade
SourceCAS 196078-29-2
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsSB-240563
ReferencePX-TA1062
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
SourceCAS 196078-29-2

This is an array with variations 106972

Example of variation sku PX-TA1062-100UG

Example of variation price 400

This is an array with variations 106973

Example of variation sku PX-TA1062-1MG

Example of variation price 1200

Contact us to order

+33 (0)3 90 20 54 70

Write us

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Mepolizumab Biosimilar – Anti-IL5 mAb – Research Grade”

Your email address will not be published.

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.